Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP standards for infant formula

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Pharmacopeia proposes adding to the Food Chemicals Codex three nucleotides found in breast milk and commonly added to infant formula, and two DHA oils. USP will add the new voluntary industry standards to the codex following a three-month public comment period ending March 31 to enhance the quality and safety of infant formulas and functional foods. The proposed nucleotide standards - for disodium 5'-uridylate, 5'-adenylic acid and 5'-cytidylic acid - designate the identity, purity and impurities of the ingredients and validated test methods, USP says. The proposed DHA standards are for DHA algal oil, crypthecodinium type and DHA algal oil, schizochytrium type. During a Jan. 14 interview, USP Director of Food Standards Markus Lipp said the standards allow marketers to approach suppliers with a set of minimum requirements for products, and allow suppliers to promote their adherence to the standards to set themselves apart from competitors

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel